Shuttle Pharmaceuticals Inc(SHPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SHPH Shuttle Pharmaceuticals Inc

Trading 08-11 12:25:49 EDT

3.96

-0.11

-2.70%

High4.10	Low3.94	Vol7.41K
Open3.99	D1 Closing4.07	Amplitude3.86%
Mkt Cap2.32M	Tradable Cap2.31M	Total Shares585.13K
T/O29.71K	T/O Rate1.27%	Tradable Shares582.38K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SHPH","market":"US","secType":"STK","nameCN":"Shuttle Pharmaceuticals Inc","latestPrice":3.96,"timestamp":1786465068147,"preClose":4.07,"halted":0,"volume":7409,"delay":0,"changeRate":-0.027027027027027105,"floatShares":582380,"shares":585129,"eps":-57.143,"marketStatus":"Trading","change":-0.11,"latestTime":"08-11 12:25:49 EDT","open":3.99,"high":4.1001,"low":3.9428,"amount":29712.1548883,"amplitude":0.038649,"askPrice":4.23,"askSize":100,"bidPrice":3.99,"bidSize":10,"shortable":0,"etf":0,"ttmEps":-57.143,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1786478400000},"marketStatusCode":2,"adr":0,"listingDate":1661918400000,"exchange":"NASDAQ","adjPreClose":4.07,"preHourTrading":{"tag":"盘前","latestPrice":3.97,"preClose":4.07,"latestTime":"09:24 EDT","volume":606,"amount":2404.6968395999997,"timestamp":1786454674209,"change":-0.1,"changeRate":-0.02457,"amplitude":0.039803},"postHourTrading":{"tag":"盘后","latestPrice":4.08,"preClose":4.07,"latestTime":"19:47 EDT","volume":525,"amount":2130.58,"timestamp":1786405635878,"change":0.01,"changeRate":0.002457,"amplitude":0.020934},"volumeRatio":0.043499},"requestUrl":"/m/hq/s/SHPH","defaultTab":"news","newsList":[{"id":"2656307305","title":"Shuttle Pharmaceuticals Announces Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2656307305","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656307305?lang=en_us&edition=fundamental","pubTime":"2026-08-04 05:17","pubTimestamp":1785791826,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals announces special shareholder meetingShuttle Pharmaceuticals will hold a virtual special shareholder meeting on Sept. 3, 2026.Shareholders will vote on share issuances tied to ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL9df3dv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHPH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651474493","title":"HRT Financial Disposes of Shuttle Pharmaceuticals Common Shares Worth $372,939.07","url":"https://stock-news.laohu8.com/highlight/detail?id=2651474493","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651474493?lang=en_us&edition=fundamental","pubTime":"2026-07-16 03:37","pubTimestamp":1784144225,"startTime":"0","endTime":"0","summary":"HRT Financial disposes of Shuttle Pharmaceuticals common shares worth $372,939.07HRT Financial LP exited its stake in Shuttle Pharmaceuticals Holdings, selling 83,149 common shares in two trades on Ju","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDLwPDRY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"HRT Financial Disposes of Shuttle Pharmaceuticals Common Shares Worth $372,939.07","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SHPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651177062","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2651177062","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651177062?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:09","pubTimestamp":1784027382,"startTime":"0","endTime":"0","summary":"NextCure  shares were up 240% in Tuesday premarket trading after the company agreed to merge with privately held Avere Therapeutics in an all-stock transaction.Picard Medical  stock was 37% higher after the company reported an 85% year-over-year increase in Q1 revenue.Shuttle Pharmaceuticals  shares were up 65% after a regulatory filing showed HRT Financial acquired additional shares of the company.Haoxi Health Technology  stock was 35% higher after the company signed a cooperation framework agreement with Nova Media.Vision Marine Technologies  shares were up 26% after the company reported a 27% sequential increase in fiscal Q3 revenue to $18.4 million.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0545562505.USD","VMAR","BK4190","LU1043141123.HKD","BK4139","SHPH","BK4009","LU0426417589.USD","LU0426412945.USD","NXTC","HAO","BK4082","LU0994945656.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651146259","title":"Shuttle Pharmaceuticals Files Initial Beneficial Ownership Statement by HRT Financial LP","url":"https://stock-news.laohu8.com/highlight/detail?id=2651146259","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651146259?lang=en_us&edition=fundamental","pubTime":"2026-07-14 02:22","pubTimestamp":1783966934,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals files initial beneficial ownership statement by HRT Financial LPHRT Financial reported a 10% ownership stake in Shuttle Pharmaceuticals in a Form 3 filing dated July 13.The filing shows direct beneficial ownership of 60,540 shares of common stock as of July 9.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 13, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL30D4yR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHPH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650773999","title":"HRT Financial LP Reports $100,368 Disposal of Shuttle Pharmaceuticals Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2650773999","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650773999?lang=en_us&edition=fundamental","pubTime":"2026-07-10 05:50","pubTimestamp":1783633853,"startTime":"0","endTime":"0","summary":"HRT Financial LP reports $100,368 disposal of Shuttle Pharmaceuticals common sharesHRT Financial LP, a 10% owner of Shuttle Pharmaceuticals, disclosed sales totaling 29,111 common shares on July 7-8.S","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL663cJr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"HRT Financial LP Reports $100,368 Disposal of Shuttle Pharmaceuticals Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SHPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649930898","title":"HRT Financial LP Sells 9,022 Shuttle Pharmaceuticals Shares for $31,672.22","url":"https://stock-news.laohu8.com/highlight/detail?id=2649930898","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649930898?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:23","pubTimestamp":1783455830,"startTime":"0","endTime":"0","summary":"HRT Financial LP sells 9,022 Shuttle Pharmaceuticals shares for $31,672.22HRT Financial LP reported open-market activity in Shuttle Pharmaceuticals common stock in early July.Bought 7,851 shares on Ju","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL1ClHDT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"HRT Financial LP Sells 9,022 Shuttle Pharmaceuticals Shares for $31,672.22","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHPH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648524763","title":"Shuttle Pharmaceuticals Files Form 3 Disclosing HRT Financial LP Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2648524763","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648524763?lang=en_us&edition=fundamental","pubTime":"2026-07-02 06:49","pubTimestamp":1782946150,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals files Form 3 disclosing HRT Financial LP stakeHRT Financial filed a Form 3 disclosing a 10% stake in Shuttle Pharmaceuticals (SHPH) as of June 29, 2026.Position totals 71,842 s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL5JLb6J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHPH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648110235","title":"Shuttle Pharma’s United Dogecoin Unit Evaluates Idaho, Alberta Behind-the-meter Power, Data Centers for DOGE Mining, AI Hosting","url":"https://stock-news.laohu8.com/highlight/detail?id=2648110235","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648110235?lang=en_us&edition=fundamental","pubTime":"2026-07-01 18:04","pubTimestamp":1782900297,"startTime":"0","endTime":"0","summary":"Shuttle Pharma’s United Dogecoin unit evaluates Idaho, Alberta behind-the-meter power, data centers for DOGE mining, AI hostingShuttle Pharmaceuticals outlined plans to evaluate proprietary data cente","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL5tb3t6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHPH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646385612","title":"Shuttle Pharma Unit United Dogecoin Evaluates Idaho, Alberta Power Assets for DOGE Mining Data Centers","url":"https://stock-news.laohu8.com/highlight/detail?id=2646385612","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646385612?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:06","pubTimestamp":1782417989,"startTime":"0","endTime":"0","summary":"Shuttle Pharma unit United Dogecoin evaluates Idaho, Alberta power assets for DOGE mining data centersShuttle Pharmaceuticals’ acquired unit United Dogecoin began evaluating proprietary data center an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL94Wx4d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SHPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642474706","title":"Shuttle Pharmaceuticals Holdings Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2642474706","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642474706?lang=en_us&edition=fundamental","pubTime":"2026-06-11 07:50","pubTimestamp":1781135459,"startTime":"0","endTime":"0","summary":"19:50 EDT Shuttle Pharmaceuticals (SHPH) Holdings Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/shuttle-pharmaceuticals-holdings-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/shuttle-pharmaceuticals-holdings-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SHPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642460830","title":"Shuttle Pharma to execute 10-for-1 reverse stock split on June 11","url":"https://stock-news.laohu8.com/highlight/detail?id=2642460830","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642460830?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:32","pubTimestamp":1781008372,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals will implement a 10-for-1 reverse stock split effective June 11, 2026, at 12:01 a.m. ET.Shares will trade on a split-adjusted basis at the June 11 open on Nasdaq under SHPH.Outstanding common shares will drop to about 637,108 from 6,371,075, excluding rounding.Fractional share entitlements will be rounded up to the next whole share.The move targets Nasdaq listing compliance, while reshaping the company’s capital structure.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDLchbkH1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SHPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640796078","title":"Shuttle Pharmaceuticals files Form 3 for Co-CEO Ryan Trasolini","url":"https://stock-news.laohu8.com/highlight/detail?id=2640796078","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640796078?lang=en_us&edition=fundamental","pubTime":"2026-06-02 07:12","pubTimestamp":1780355536,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals said Co-Chief Executive Officer Ryan Trasolini filed an initial statement of beneficial ownership on May 6, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL706w9b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SHPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638838716","title":"Shuttle Pharmaceuticals shareholders approve reverse stock split authorization at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638838716","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638838716?lang=en_us&edition=fundamental","pubTime":"2026-05-27 21:02","pubTimestamp":1779886953,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals Holdings held its annual shareholder meeting on May 21, 2026.An advisory vote backed the pay packages for the company’s named executive officers.Shareholders authorized the board to pursue a reverse stock split within a 1-for-2 to 1-for-150 range; no split was confirmed as executed.Shareholders also authorized adjournment of the meeting, though it was not required.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible for the information contained ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL8rvdv5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SHPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635866055","title":"Shuttle Pharmaceuticals Q1 EPS $(0.43) Up From $(7.60) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2635866055","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635866055?lang=en_us&edition=fundamental","pubTime":"2026-05-16 06:19","pubTimestamp":1778883557,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(0.43) per share. This is a 94.34 percent increase over losses of $(7.60) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52620267/shuttle-pharmaceuticals-q1-eps-0-43-up-from-7-60-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Shuttle Pharmaceuticals Q1 EPS $(0.43) Up From $(7.60) YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQ","PSQ","MNQmain","BK4139","QYLG","TQQQ","TECS","NQmain","JEPQ","QQQJ","TQQY","NDX","FTEC","IYW","QDTE","QLD","QQQY","SQQQ","NVIW.SI",".IXIC","QQQE","QID","SHPH","GPIQ","QQQA","ONEQ","QQQM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635903073","title":"Shuttle Pharma Q1 FY26 net loss narrows 29% to $2.15 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635903073","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635903073?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:39","pubTimestamp":1778877591,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals posted a net loss of USD 2.15 million for the quarter ended March 31, 2026, narrowing 29%.Operating loss tightened 25% to USD 2.22 million on total operating expenses of USD 2.22 million.Research and development expense fell 83% to 267,240, while general and administrative costs rose 94% to USD 1.16 million.Cash and cash equivalents totaled USD 1.09 million, down 76%, with operating cash outflow of USD 2.42 million.Company closed a March 9 underwritten public offering, generating USD 3.5 million in gross proceeds and using USD 1.25 million of net proceeds for marketing efforts tied to Molecule.ai.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL8dfX9s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHPH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633120649","title":"Shuttle Pharmaceuticals closes United Dogecoin acquisition, creating public Dogecoin miner platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2633120649","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633120649?lang=en_us&edition=fundamental","pubTime":"2026-05-08 02:03","pubTimestamp":1778176981,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals completed acquisition of United Dogecoin via merger of United Dogecoin into a wholly owned Shuttle subsidiary, creating one of largest publicly traded Dogecoin mining platforms.Transaction included concurrent USD 9.6 million PIPE financing, closed May 6, 2026, to fund scale-up of mining operations.Next-generation ElphaPex mining rigs expected to be fully operational within 60 days, targeting up to 43,200 GH/s hash rate.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL1xnQBt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHPH","SG9999014005.SGD","SG9999014039.USD","BK4585","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU0314104364.USD","BK4139","IE00BKPKM429.USD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","LU2210150020.SGD","BK4588","LU2210149790.SGD","SG9999014021.USD","IE00BN0W2W23.USD","LU2095319765.USD","SG9999014013.SGD","NDAQ","IE00BN0W2T93.GBP","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633120664","title":"E.f. Hutton & Co. Serves as Exclusive M&a Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin Miner","url":"https://stock-news.laohu8.com/highlight/detail?id=2633120664","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633120664?lang=en_us&edition=fundamental","pubTime":"2026-05-08 02:02","pubTimestamp":1778176954,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA2SVFGM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SHPH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632176946","title":"Shuttle Pharmaceuticals agrees to merge with Dogecoin miner United Dogecoin","url":"https://stock-news.laohu8.com/highlight/detail?id=2632176946","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632176946?lang=en_us&edition=fundamental","pubTime":"2026-05-01 21:25","pubTimestamp":1777641912,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceutical entered definitive merger agreement to acquire Dogecoin miner United Dogecoin, which will become wholly owned subsidiary.Consideration includes 8,000 shares of Series B-1 Convertible Preferred Stock, convertible at USD 1.24 into about 32,258,064 common shares, subject to stockholder approval.Deal also provides up to 118,038,551 pre-funded warrants tied to post-closing operational milestones, issuable only if stockholder approval is obtained.Post-merger board plans to appoint United Dogecoin CEO Ryan Trasolini as co-CEO alongside Christopher Cooper, with CFO Yuying Liang continuing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL69WK9G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SHPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626143921","title":"Shuttle Pharmaceuticals announces annual shareholder meeting via webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2626143921","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626143921?lang=en_us&edition=fundamental","pubTime":"2026-04-11 05:13","pubTimestamp":1775855615,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals scheduled 2026 annual shareholder meeting for May 21, 2026 via live webcast.Shareholders will vote on election of five directors.Advisory vote will be held on executive compensation.Investors will also consider authorizing board to implement one or more reverse stock splits within 1-for-2 to 1-for-150 range, plus approval to adjourn meeting if needed to secure votes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 10, 2026, and is solely responsible for the information contai","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL9j41Ws:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SHPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624537708","title":"Shuttle Pharma FY25 net loss widens 28% to $11.7 million; operating loss deepens to $11.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624537708","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624537708?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:16","pubTimestamp":1774988212,"startTime":"0","endTime":"0","summary":"Shuttle Pharmaceuticals posted a net loss of USD 12 million for fiscal year 2025, widening 28%.Revenue was unchanged at no revenue, while operating loss expanded to USD 12 million.Research and development expense rose 12% to USD 4.1 million, while general and administrative expense more than quadrupled to USD 5.7 million.Completed acquisition of Molecule.ai assets in November, paying USD 3 million in cash; committed to wind down ropidoxuridine clinical trials.Outlook: future research and development activities expected to cease until it determines direction of preclinical and clinical drug development efforts.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to gen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLbYgfyY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SHPH"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.shuttlepharma.com","stockEarnings":[{"period":"1week","weight":0.2077},{"period":"1month","weight":0.3938},{"period":"3month","weight":-0.38},{"period":"6month","weight":-0.6366},{"period":"1year","weight":-0.881},{"period":"ytd","weight":-0.7739}],"compareEarnings":[{"period":"1week","weight":0.0203},{"period":"1month","weight":0.0239},{"period":"3month","weight":0.0472},{"period":"6month","weight":0.1172},{"period":"1year","weight":0.2132},{"period":"ytd","weight":0.1336}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas, SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers. The company was founded in 2012 and is based in Rockville, Maryland.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.048599},{"month":2,"riseRate":0.5,"avgChangeRate":-0.170656},{"month":3,"riseRate":0.25,"avgChangeRate":-0.234438},{"month":4,"riseRate":0.75,"avgChangeRate":0.112025},{"month":5,"riseRate":0.25,"avgChangeRate":-0.214772},{"month":6,"riseRate":0.25,"avgChangeRate":-0.182774},{"month":7,"riseRate":0.5,"avgChangeRate":-0.019591},{"month":8,"riseRate":0.25,"avgChangeRate":-0.149885},{"month":9,"riseRate":0.25,"avgChangeRate":-0.322851},{"month":10,"riseRate":0.25,"avgChangeRate":-0.104427},{"month":11,"riseRate":0.25,"avgChangeRate":-0.361431},{"month":12,"riseRate":0.75,"avgChangeRate":0.133405}],"exchange":"NASDAQ","name":"Shuttle Pharmaceuticals Inc","nameEN":"Shuttle Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Shuttle Pharmaceuticals Inc(SHPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Shuttle Pharmaceuticals Inc(SHPH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Shuttle Pharmaceuticals Inc,SHPH,Shuttle Pharmaceuticals Inc股票,Shuttle Pharmaceuticals Inc股票老虎,Shuttle Pharmaceuticals Inc股票老虎国际,Shuttle Pharmaceuticals Inc行情,Shuttle Pharmaceuticals Inc股票行情,Shuttle Pharmaceuticals Inc股价,Shuttle Pharmaceuticals Inc股市,Shuttle Pharmaceuticals Inc股票价格,Shuttle Pharmaceuticals Inc股票交易,Shuttle Pharmaceuticals Inc股票购买,Shuttle Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Shuttle Pharmaceuticals Inc(SHPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Shuttle Pharmaceuticals Inc(SHPH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}